404 related articles for article (PubMed ID: 197458)
21. Serum relaxin in patients with hydatidiform mole.
Seki K; Uesato T; Tabei T; Kato K
Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
[TBL] [Abstract][Full Text] [Related]
22. [Radioimmunologic and radioreceptor analysis of human chorionic gonadotropin for the diagnosis and control of ectopic pregnancy].
Conte N; Testa D; Barbero P; Diani F
Boll Soc Ital Biol Sper; 1982 Aug; 58(15):977-81. PubMed ID: 7126372
[TBL] [Abstract][Full Text] [Related]
23. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
24. Assessment of rapid radioimmunoassay for urinary beta-human chorionic gonadotropin (beta hCG-RIA) in early pregnancy.
Xu RQ; Li YY; Zhou SZ; Fei RT; Liu YH
Acta Acad Med Wuhan; 1984; 4(2):105-8. PubMed ID: 6204259
[TBL] [Abstract][Full Text] [Related]
25. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
Dawood MY; Saxena BB
Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
[TBL] [Abstract][Full Text] [Related]
26. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
Kamariah K; Satgunasingam N; Nasri NM; Ng KY
Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
[TBL] [Abstract][Full Text] [Related]
27. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
28. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
30. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
31. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
32. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
34. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
35. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
Shapiro AI; Wu TF; Ballon SC; Lamb EJ
Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of trophoblastic neoplasms through radioimmunoassay of the urinary carboxy-terminal fragment of beta-choriogonadotropin (COOH-beta-HCG-RIA).
Ayala AR; González E; Castorena G; de Jesús Montoya J
Arch Invest Med (Mex); 1984; 15(2):139-45. PubMed ID: 6207791
[No Abstract] [Full Text] [Related]
38. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
39. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
40. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
